Branden RYU is the founder of BIORCHESTRA. BIORCHESTRA has raised $79M in total funding. Latest round: Series C. Based in Seoul, South Korea.
Branden RYU is the CEO of BIORCHESTRA, a leading RNA therapeutics company focused on neurodegenerative diseases. The company utilizes proprietary RNA-based drug and drug delivery platforms. BIORCHESTRA recently completed a $45 million USD Series C fundraising round.
Full founder directory · Investor directory · Company funding database · Fundraising library